level	trait	total_gwas_snps	trait_snps	eqtls_in_catalog	trait_eqtls	pval	adj_pval	sim_count	sim_pval
level0	White matter microstructure (mean diusivities)	344506	198	2410	20	2.92718094697669e-17	5.5206632659980376e-14	17	0.036
level0	White matter microstructure (radial diusivities)	344506	250	2410	16	4.6122037858659725e-11	8.698616340143225e-08	27	0.056
level0	White matter microstructure (axial diusivities)	344506	160	2410	17	2.9223806786327303e-15	5.511609959901329e-12	7	0.016
level0	Hemoglobin concentration	344506	1081	2410	27	2.6882618626791974e-08	5.0700618730129664e-05	43	0.088
level0	White matter microstructure (fractional anisotropy)	344506	240	2410	15	2.564309521710794e-10	4.836287757946557e-07	31	0.064
level0	Neuroticism	344506	1057	2410	32	1.2770736773810355e-11	2.408560955540633e-08	31	0.064
level0	Alzheimer's disease	344506	342	2410	43	1.8812750689813367e-39	3.5480847800988014e-36	9	0.02
level0	Parkinson's disease	344506	374	2410	39	9.463742973071137e-33	1.784861924721217e-29	21	0.044
level0	Alzheimer's disease in APOE e4- carriers	344506	35	2410	6	1.5891682451942018e-07	0.0002997171310436	9	0.02
level0	Chronic hepatitis B infection	344506	19	2410	5	1.7880473679653397e-07	0.0003372257335982	18	0.038
level0	Systemic lupus erythematosus	344506	863	2410	34	1.8794997958673324e-15	3.544736615005789e-12	35	0.072
level0	Coronary artery disease	344506	1580	2410	98	6.1916068429811285e-59	1.1677370505862406e-55	20	0.042
level0	Hepatitis B	344506	50	2410	6	1.4224812313212168e-06	0.0026827996022718	9	0.02
level0	IgA nephropathy	344506	159	2410	12	1.8503346601732131e-09	3.489731169086681e-06	12	0.026
level0	Oligoclonal band status in multiple sclerosis	344506	4	2410	3	1.360510734729447e-06	0.0025659232456997	8	0.018
level0	Rheumatic heart disease	344506	25	2410	6	1.840794492653057e-08	3.471738413143665e-05	2	0.006
level0	Sarcoidosis	344506	146	2410	9	1.082344041491084e-06	0.0020413008622521	11	0.024
level0	Hepatitis C induced liver cirrhosis	344506	5	2410	3	3.383459829968917e-06	0.0063812052393213	8	0.018
level0	Nodular sclerosis Hodgkin lymphoma	344506	14	2410	5	3.1694546358275694e-08	5.977591443170796e-05	11	0.024
level0	Alzheimer's disease (late onset)	344506	123	2410	18	1.3265591950706077e-18	2.5018906419031656e-15	5	0.012
level0	Lymphoma	344506	9	2410	4	2.9269584941832135e-07	0.0005520243720029	12	0.026
level0	Multiple sclerosis (OCB status)	344506	10	2410	6	2.388001858418484e-11	4.5037715049772617e-08	11	0.024
level0	Parkinson's disease or first degree relation to individual with Parkinson's disease	344506	107	2410	10	5.235130900456234e-09	9.873456878260458e-06	2	0.006
level0	Cortical surface area (global PC1)	344506	15	2410	5	4.726565253911409e-08	8.914302068876918e-05	4	0.01
level0	Post bronchodilator FEV1	344506	1182	2410	40	1.043958554156822e-15	1.968905833139766e-12	18	0.038
level0	Post bronchodilator FEV1/FVC ratio	344506	1627	2410	48	2.996130174138202e-16	5.650701508424649e-13	9	0.02
level0	ACPA-positive rheumatoid arthritis (smoking interaction)	344506	15	2410	11	2.5537297961577682e-21	4.816334395553552e-18	15	0.032
level0	Epstein Barr virus nuclear antigen 1 IgG levels	344506	6	2410	3	6.731484687597394e-06	0.0126955801208086	12	0.026
level0	Primary central nervous system lymphoma	344506	7	2410	3	1.1718433330778134e-05	0.0221009652618475	6	0.014
level0	Immunoglobulin A vasculitis	344506	60	2410	18	1.0595681072524971e-24	1.9983454502782094e-21	17	0.036
level0	HLA DR on myeloid Dendritic Cell	344506	5	2410	3	3.383459829968917e-06	0.0063812052393213	3	0.008
level0	HLA DR on plasmacytoid Dendritic Cell	344506	8	2410	3	1.8651380367702197e-05	0.0351765033734863	3	0.008
level0	Persistent hepatitis B virus infection	344506	8	2410	4	1.6352158407051258e-07	0.0003084017075569	11	0.024
level0	Alzheimer's disease or family history of Alzheimer's disease	344506	309	2410	49	7.948877635031373e-50	1.4991583219669171e-46	26	0.054
level0	Family history of Alzheimer's disease	344506	87	2410	19	4.67623223287602e-23	8.819373991204173e-20	8	0.018
level0	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	344506	5	2410	3	3.383459829968917e-06	0.0063812052393213	0	0.002
level0	Giant cell arteritis	344506	8	2410	3	1.8651380367702197e-05	0.0351765033734863	9	0.02
level0	Experiencing mood swings	344506	69	2410	6	9.582315609561723e-06	0.0180722472396334	6	0.014
level0	Feeling worry	344506	71	2410	6	1.1312663375820031e-05	0.0213356831267965	14	0.03
level0	Irritable mood	344506	67	2410	8	2.564519646858636e-08	4.836684053975388e-05	7	0.016
level0	Response to hepatitis B vaccine	344506	21	2410	4	1.3001167931422087e-05	0.024520202718662	17	0.036
level0	Feeling guilty	344506	29	2410	7	1.108887130681491e-09	2.091361128465293e-06	7	0.016
level0	Waist-to-hip ratio adjusted for BMI	344506	3741	2410	59	1.6859585979617883e-08	3.1797179157559326e-05	91	0.184
level0	Childhood steroid-sensitive nephrotic syndrome	344506	29	2410	6	4.8206256542710285e-08	9.09169998395516e-05	11	0.024
level0	A body shape index	344506	1514	2410	35	1.866883039837714e-09	3.520941413133929e-06	78	0.158
level0	Waist-hip index	344506	2526	2410	50	1.5992911682929695e-10	3.016263143400541e-07	84	0.17
level0	Major depressive disorder or stress-related disorder	344506	242	2410	23	4.998793559035766e-19	9.427724652341454e-16	11	0.024
level0	Alpha-L-iduronidase levels (IDUA.3169.70.2)	344506	7	2410	4	8.221985066850057e-08	0.0001550666383607	10	0.022
level0	Non-lobar intracerebral hemorrhage (MTAG)	344506	42	2410	5	1.1444536498785075e-05	0.0215843958367086	10	0.022
level0	Depressed affect	344506	157	2410	12	1.601158003050189e-09	3.019783993752657e-06	5	0.012
level0	Worry	344506	147	2410	9	1.1457646327023738e-06	0.0021609120972766	19	0.04
level0	General factor of neuroticism	344506	308	2410	17	1.1668204371644468e-10	2.2006233444921466e-07	28	0.058
level0	Alzheimer's disease or peptic ulcer disease	344506	31	2410	7	1.845547056437662e-09	3.4807017484414303e-06	1	0.004
level0	Mitogen-activated protein kinase 3 levels	344506	4	2410	3	1.360510734729447e-06	0.0025659232456997	10	0.022
level0	Complement C4 levels	344506	43	2410	5	1.2875525577907668e-05	0.0242832412399338	10	0.022
level0	Cathepsin H levels (CTSH.8465.52.3)	344506	5	2410	3	3.383459829968917e-06	0.0063812052393213	2	0.006
level0	Complement C4 levels (C4A.C4B.4481.34.2)	344506	27	2410	5	1.184941009228238e-06	0.0022347987434044	5	0.012
level0	HLA class II histocompatibility antigen, DQ alpha 2 chain levels (HLA.DQA2.7757.5.3)	344506	5	2410	3	3.383459829968917e-06	0.0063812052393213	3	0.008
level0	Succinylcarnitine levels	344506	18	2410	6	2.0121602365418284e-09	3.794934206117888e-06	6	0.014
level0	Triacylglycerol (50:2) [NL-18:2] levels	344506	7	2410	3	1.1718433330778134e-05	0.0221009652618475	11	0.024
level0	Cathepsin H levels	344506	13	2410	8	7.073377028432296e-15	1.3340389075623311e-11	3	0.008
level0	Vaginal microbiome MetaCyc pathway (FUCCAT-PWY|fucose degradation)	344506	35	2410	6	1.5891682451942018e-07	0.0002997171310436	8	0.018
level0	Rheumatoid arthritis or irritable bowel disease	344506	86	2410	11	2.906995750723336e-11	5.482593985864212e-08	44	0.09
level0	Alzheimerâ€™s disease polygenic risk score (upper quantile vs lower quantile)	344506	477	2410	14	9.681735923677704e-06	0.0182597539520561	1	0.004
level0	COVID-19 hospitalization or systemic lupus erythematosus (MTAG)	344506	17	2410	4	5.286829131588928e-06	0.0099709597421767	1	0.004
level0	Pediatric steroid sensitive nephrotic syndrome	344506	41	2410	6	4.247186118787229e-07	0.0008010193020032	10	0.022
level0	BMI at 1.5 -2.5 years old interval	344506	4	2410	3	1.360510734729447e-06	0.0025659232456997	6	0.014
level0	Posterolateral temporal area (unadjusted for global measures)	344506	33	2410	6	1.0974176641786397e-07	0.000206972971464	8	0.018
level0	Dorsomedial frontal area (unadjusted for global measures)	344506	54	2410	6	2.2574510290180885e-06	0.0042575526407281	6	0.014
level0	Parsopercularis area (unadjusted for global measures)	344506	46	2410	6	8.587424945530974e-07	0.0016195883447271	4	0.01
level0	Occipital area (unadjusted for global measures)	344506	45	2410	7	2.92406466944036e-08	5.51478596656452e-05	7	0.016
level0	Middle temporal thickness (unadjusted for global measures)	344506	23	2410	4	1.902217546108773e-05	0.0358758229196114	4	0.01
level0	Anteromedial temporal area (unadjusted for global measures)	344506	29	2410	5	1.7229191928696792e-06	0.0032494255977522	4	0.01
level0	Dorsolateral prefrontal area (unadjusted for global measures)	344506	48	2410	6	1.1116922410950994e-06	0.0020966515667053	4	0.01
level0	COVID-19 severity	344506	47	2410	7	4.003320330109597e-08	7.5502621425867e-05	9	0.02
level0	Motor premotor area (unadjusted for global measures)	344506	39	2410	5	7.881960673413503e-06	0.0148653778300578	4	0.01
level0	Inferior parietal area (unadjusted for global measures)	344506	45	2410	7	2.92406466944036e-08	5.51478596656452e-05	5	0.012
level0	Precuneus area (unadjusted for global measures)	344506	34	2410	5	3.921418094378803e-06	0.0073957945259984	6	0.014
level0	Superior parietal area (unadjusted for global measures)	344506	30	2410	6	5.98984293492075e-08	0.0001129684377526	6	0.014
level0	Allergen component sensitization (Ambrosia artemisiifolia 1)	344506	75	2410	69	1.4295075696253288e-141	2.69605127631337e-138	7	0.016
level0	Allergen component sensitization (Hevea brasiliensis 8)	344506	77	2410	27	1.7524561928635398e-38	3.3051323797406357e-35	12	0.026
level0	Breast cancer or hospitalized COVID-19 (pleiotropy)	344506	7	2410	3	1.1718433330778134e-05	0.0221009652618475	5	0.012
level0	Breast cancer or critical COVID-19 (pleiotropy)	344506	6	2410	3	6.731484687597394e-06	0.0126955801208086	8	0.018
level0	Ovarian cancer or hospitalized COVID-19 (pleiotropy)	344506	6	2410	4	3.543496913497753e-08	6.683035178856762e-05	5	0.012
level0	Ovarian cancer or critical COVID-19 (pleiotropy)	344506	4	2410	3	1.360510734729447e-06	0.0025659232456997	8	0.018
level0	Major depressive disorder or hospitalized COVID-19 (pleiotropy)	344506	6	2410	3	6.731484687597394e-06	0.0126955801208086	1	0.004
level0	Hypothyroidism or rheumatoid arthritis (pleiotropy)	344506	1035	2410	63	6.856943211134796e-38	1.2932194896200223e-34	98	0.198
level0	Seropositivity for human adenovirus 12 peptide (twist_55551)	344506	4	2410	3	1.360510734729447e-06	0.0025659232456997	8	0.018
level0	Seropositivity for gallus gallus ovomucoid precursor gallus peptide (twist_28164)	344506	7	2410	4	8.221985066850057e-08	0.0001550666383607	10	0.022
level0	Seropositivity for root peptide (agilent_184788)	344506	3	2410	3	3.419193953031698e-07	0.0006448599795417	9	0.02
level0	Seropositivity for struthio camelus (ostrich) peptide (twist_5109)	344506	8	2410	3	1.8651380367702197e-05	0.0351765033734863	13	0.028
level0	Seropositivity for staphylococcus aureus subsp. aureus MRSA252 peptide (agilent_80555)	344506	4	2410	3	1.360510734729447e-06	0.0025659232456997	6	0.014
level0	Seropositivity for escherichia coli O157:H7 str. sakai peptide (agilent_90858)	344506	4	2410	4	2.388948672289492e-09	4.505557195937983e-06	1	0.004
level0	Seropositivity for streptococcus pneumoniae peptide (twist_48171)	344506	3	2410	3	3.419193953031698e-07	0.0006448599795417	8	0.018
level0	Seropositivity for shigella flexneri 2a str. 301 peptide (agilent_182601)	344506	5	2410	3	3.383459829968917e-06	0.0063812052393213	1	0.004
level0	Seropositivity for human gammaherpesvirus 4 (Epstein-Barr virus) peptide (twist_46937)	344506	4	2410	3	1.360510734729447e-06	0.0025659232456997	10	0.022
level0	Seropositivity for human gammaherpesvirus 4 (Epstein-Barr virus) peptide (agilent_212)	344506	3	2410	3	3.419193953031698e-07	0.0006448599795417	4	0.01
level0	Seropositivity for human gammaherpesvirus 4 (Epstein-Barr virus) peptide (twist_46426)	344506	3	2410	3	3.419193953031698e-07	0.0006448599795417	4	0.01
level0	Seropositivity for gallus peptide (twist_24274)	344506	7	2410	3	1.1718433330778134e-05	0.0221009652618475	10	0.022
level0	Seropositivity for lactobacillus phage LFEINF peptide (twist_88894)	344506	18	2410	5	1.325201443459082e-07	0.0002499329922363	22	0.046
level0	Seropositivity for lactobacillus phage LFEINF peptide (twist_64023)	344506	18	2410	4	6.759488841258109e-06	0.0127483959546127	20	0.042
level0	Seropositivity for staphylococcus aureus peptide (twist_38683)	344506	5	2410	3	3.383459829968917e-06	0.0063812052393213	8	0.018
level0	Seropositivity for staphylococcus aureus peptide (twist_39975)	344506	9	2410	4	2.9269584941832135e-07	0.0005520243720029	9	0.02
level0	Seropositivity for staphylococcus aureus subsp. aureus MW2 peptide (agilent_237201)	344506	6	2410	3	6.731484687597394e-06	0.0126955801208086	10	0.022
level0	Seropositivity for staphylococcus aureus peptide (agilent_241121)	344506	4	2410	3	1.360510734729447e-06	0.0025659232456997	11	0.024
level1	General cognitive ability	344506	1258	1117	15	2.258943540367663e-05	0.0206919228297677	26	0.054
level1	White matter microstructure (mean diusivities)	344506	198	1117	11	7.914517078826466e-11	7.249697644205042e-08	18	0.038
level1	White matter microstructure (radial diusivities)	344506	250	1117	9	1.7368468243495925e-07	0.0001590951691104	31	0.064
level1	White matter microstructure (axial diusivities)	344506	160	1117	10	1.8097108870079435e-10	1.657695172499276e-07	10	0.022
level1	Cortical thickness	344506	632	1117	10	5.2848563379665286e-05	0.0484092840557734	2	0.006
level1	White matter microstructure (fractional anisotropy)	344506	240	1117	8	1.490629255876653e-06	0.001365416398383	40	0.082
level1	Neuroticism	344506	1057	1117	24	2.863352215122112e-13	2.6228306290518537e-10	60	0.122
level1	Parkinson's disease	344506	374	1117	18	9.843743210341372e-16	9.016868780672696e-13	23	0.048
level1	HDL cholesterol levels x long total sleep time interaction (1df test)	344506	3	1117	2	3.144185910561144e-05	0.02880074294074	57	0.116
level1	Cortical surface area (global PC1)	344506	15	1117	6	5.596320248581606e-12	5.126229347700751e-09	8	0.018
level1	Meningococcal C functional antibody titers post childhood immunization	344506	6	1117	4	1.6403682150559943e-09	1.502577284991291e-06	17	0.036
level1	IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L	344506	2	1117	2	1.0503282541828071e-05	0.0096210068083145	7	0.016
level1	IDP dMRI ProbtrackX MD atr l	344506	3	1117	2	3.144185910561144e-05	0.02880074294074	4	0.01
level1	IDP dMRI TBSS L3 Anterior limb of internal capsule R	344506	3	1117	2	3.144185910561144e-05	0.02880074294074	4	0.01
level1	IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R	344506	3	1117	2	3.144185910561144e-05	0.02880074294074	4	0.01
level1	IDP dMRI ProbtrackX L1 ptr l	344506	2	1117	2	1.0503282541828071e-05	0.0096210068083145	7	0.016
level1	IDP dMRI ProbtrackX L1 str r	344506	3	1117	2	3.144185910561144e-05	0.02880074294074	4	0.01
level1	aseg global volume BrainSegNotVentSurf	344506	3	1117	2	3.144185910561144e-05	0.02880074294074	4	0.01
level1	aseg global volume SupraTentorialNotVent	344506	2	1117	2	1.0503282541828071e-05	0.0096210068083145	7	0.016
level1	Reaction time	344506	539	1117	13	3.849989894794046e-08	3.5265907436313464e-05	8	0.018
level1	Experiencing mood swings	344506	69	1117	6	1.1546440701047069e-07	0.0001057653968215	8	0.018
level1	Feeling hurt	344506	46	1117	4	1.6094446423281072e-05	0.0147425129237254	5	0.012
level1	Feeling worry	344506	71	1117	5	3.872520726661143e-06	0.0035472289856216	13	0.028
level1	Blood urea nitrogen levels	344506	749	1117	12	8.636712170739593e-06	0.0079112283483974	2	0.006
level1	Irritable mood	344506	67	1117	6	9.665367667749021e-08	8.853476783658104e-05	11	0.024
level1	Feeling guilty	344506	29	1117	5	3.953691462832201e-08	3.621581379954296e-05	12	0.026
level1	Feeling fed-up	344506	60	1117	4	4.639139460292947e-05	0.0424945174562833	1	0.004
level1	Depressed affect	344506	157	1117	8	5.9425281173622535e-08	5.443355755503824e-05	8	0.018
level1	Worry	344506	147	1117	7	6.346176965822797e-07	0.0005813098100693	25	0.052
level1	General factor of neuroticism	344506	308	1117	12	6.491318264116672e-10	5.946047529930872e-07	34	0.07
level1	Alzheimer's disease (age of onset) in APOE e4 non-carriers	344506	9	1117	3	2.8142339471607504e-06	0.0025778382955992	8	0.018
level1	GM3 ganglioside (d18:1/24:0) levels	344506	4	1117	3	1.356472812473018e-07	0.0001242529096225	5	0.012
level1	Low affinity immunoglobulin gamma Fc region receptor II-b levels (FCGR2B.3310.62.1)	344506	8	1117	3	1.880713487130578e-06	0.0017227335542116	6	0.014
level1	Phosphatidylinositol(34:2)_[M-H]1- levels	344506	91	1117	20	7.321582788165985e-31	6.706569833960043e-28	41	0.084
level1	Phosphatidylinositol(34:1)_[M-H]1- levels	344506	19	1117	6	3.0003673626926985e-11	2.748336504226512e-08	27	0.056
level1	Phosphatidylinositol(35:2)_[M-H]1- levels	344506	19	1117	6	3.0003673626926985e-11	2.748336504226512e-08	27	0.056
level1	Phosphatidylinositol(36:2)_[M-H]1- levels	344506	369	1117	20	2.569022859571797e-18	2.3532249393677665e-15	44	0.09
level1	Phosphatidylinositol(40:5)_[M-H]1- levels	344506	19	1117	6	3.0003673626926985e-11	2.748336504226512e-08	27	0.056
level1	Phosphatidylinositol(40:6)_[M-H]1- levels	344506	67	1117	11	4.318357915793162e-16	3.955615850866537e-13	32	0.066
level1	Schizophrenia or ER positive breast cancer (pleiotropy)	344506	17	1117	3	2.234427765383426e-05	0.0204673583309121	5	0.012
level1	Low affinity immunoglobulin gamma Fc region receptor II-b levels	344506	57	1117	4	3.7870662279017273e-05	0.0346895266475798	6	0.014
level1	Killer cell immunoglobulin-like receptor 2DL5A levels (KIR2DL5A.8000.17.3)	344506	13	1117	3	9.489292565670416e-06	0.0086921919901541	24	0.05
level1	5-oxoproline levels	344506	10	1117	3	4.010593326911582e-06	0.003673703487451	24	0.05
level1	Posterolateral temporal area (unadjusted for global measures)	344506	33	1117	5	7.81707653664416e-08	7.16044210756605e-05	8	0.018
level1	Dorsomedial frontal area (unadjusted for global measures)	344506	54	1117	6	2.5927704839931536e-08	2.3749777633377287e-05	8	0.018
level1	Parsopercularis area (unadjusted for global measures)	344506	46	1117	6	9.613319263262552e-09	8.805800445148497e-06	8	0.018
level1	Occipital area (unadjusted for global measures)	344506	45	1117	8	2.30946147154974e-12	2.1154667079395613e-09	8	0.018
level1	Orbitofrontal area (unadjusted for global measures)	344506	41	1117	5	2.415779469665443e-07	0.0002212853994213	8	0.018
level1	Anteromedial temporal area (unadjusted for global measures)	344506	29	1117	6	5.109690285146553e-10	4.680476301194244e-07	8	0.018
level1	Dorsolateral prefrontal area (unadjusted for global measures)	344506	48	1117	7	2.424715677947335e-10	2.221039560999759e-07	8	0.018
level1	COVID-19 severity	344506	47	1117	6	1.0989751976525425e-08	1.0066612810497288e-05	10	0.022
level1	Motor premotor area (unadjusted for global measures)	344506	39	1117	4	8.259857805508276e-06	0.0075660297498455	6	0.014
level1	Inferior parietal area (unadjusted for global measures)	344506	45	1117	7	1.5071088938612512e-10	1.3805117467769062e-07	8	0.018
level1	Superior temporal area (unadjusted for global measures)	344506	39	1117	5	1.8660249553436504e-07	0.0001709278859094	8	0.018
level1	Precuneus area (unadjusted for global measures)	344506	34	1117	6	1.426827645819665e-09	1.3069741235708132e-06	8	0.018
level1	Superior parietal area (unadjusted for global measures)	344506	30	1117	7	7.053220196497278e-12	6.460749699991507e-09	8	0.018
level1	Medial temporal thickness (unadjusted for global measures)	344506	15	1117	3	1.5023587904090785e-05	0.0137616065201471	4	0.01
level1	Inferior parietal thickness (unadjusted for global measures)	344506	21	1117	3	4.328140697910321e-05	0.0396457687928585	5	0.012
level1	Ventromedial occipital thickness (unadjusted for global measures)	344506	32	1117	4	3.676991102859734e-06	0.0033681238502195	7	0.016
level1	Ventral frontal thickness (unadjusted for global measures)	344506	29	1117	4	2.447469313612067e-06	0.0022418818912686	7	0.016
level1	Corpus callosum fractional anisotropy (body)	344506	21	1117	3	4.328140697910321e-05	0.0396457687928585	1	0.004
level1	Breast cancer or hospitalized COVID-19 (pleiotropy)	344506	7	1117	3	1.1783017580214677e-06	0.0010793244103476	8	0.018
level1	Breast cancer or critical COVID-19 (pleiotropy)	344506	6	1117	3	6.749514191765783e-07	0.0006182554999657	8	0.018
level1	Ovarian cancer or hospitalized COVID-19 (pleiotropy)	344506	6	1117	3	6.749514191765783e-07	0.0006182554999657	8	0.018
level1	Ovarian cancer or critical COVID-19 (pleiotropy)	344506	4	1117	3	1.356472812473018e-07	0.0001242529096225	8	0.018
level2	Type 2 diabetes	344506	2837	2666	45	8.837651033104983e-06	0.0147500395742522	20	0.042
level2	Eosinophil counts	344506	2100	2666	41	1.4451216574163034e-07	0.0002411908046227	192	0.385
level2	Platelet count	344506	3349	2666	59	1.21349274421525e-08	2.025319390095252e-05	74	0.15
level2	Ulcerative colitis	344506	307	2666	14	1.828839571907648e-07	0.0003052333245513	87	0.176
level2	Takayasu arteritis	344506	144	2666	12	1.8226544534366561e-09	3.0420102827857794e-06	106	0.214
level2	Monocyte count	344506	1767	2666	33	5.623778586952505e-06	0.0093860864616237	160	0.321
level2	Neutrophil count	344506	1560	2666	30	8.438145992881256e-06	0.0140832656621188	211	0.423
level2	MHC class I polypeptide-related sequence A levels	344506	79	2666	15	6.975634975070126e-17	1.164233477339204e-13	126	0.253
level2	Shingles	344506	86	2666	7	5.199595303160471e-06	0.0086781245609748	24	0.05
level2	Meningococcal C functional antibody titers post childhood immunization	344506	6	2666	5	1.6483376543589938e-10	2.751075545125161e-07	70	0.142
level2	Aspartate aminotransferase platelet ratio index in high alcohol intake	344506	46	2666	5	2.91140209219077e-05	0.0485913009186639	11	0.024
level2	Fibrosis-4 index in high alcohol intake	344506	43	2666	5	2.0842007235996366e-05	0.0347853100768779	9	0.02
level2	Forns index in high alcohol intake	344506	46	2666	5	2.91140209219077e-05	0.0485913009186639	8	0.018
level2	APP/SPARC protein level ratio	344506	6	2666	3	9.09834706642121e-06	0.0151851412538569	0	0.002
level2	Serum levels of protein CTSB	344506	4	2666	3	1.8409408736098328e-06	0.0030725303180548	12	0.026
level2	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	344506	25	2666	5	1.291359663310493e-06	0.0021552792780652	55	0.112
level2	Waist-to-hip ratio adjusted for BMI	344506	3741	2666	64	8.875689982426209e-09	1.4813526580669342e-05	231	0.463
level2	Hip circumference adjusted for BMI	344506	3359	2666	72	4.70496020728696e-14	7.852578585961937e-11	204	0.409
level2	Platelet-to-lymphocyte ratio	344506	312	2666	12	7.69256596872767e-06	0.0128388926018064	12	0.026
level2	Waist-hip index	344506	2526	2666	55	2.458945770019993e-11	4.103980490163368e-08	239	0.479
level2	Acid sphingomyelinase-like phosphodiesterase 3a levels (SMPDL3A.14086.11.3)	344506	6	2666	3	9.09834706642121e-06	0.0151851412538569	25	0.052
level2	Alpha-L-iduronidase levels (IDUA.3169.70.2)	344506	7	2666	3	1.582990639059282e-05	0.0264201137658994	24	0.05
level2	Cathepsin B levels	344506	43	2666	6	1.0190502340279538e-06	0.0017007948405926	13	0.028
level2	Cathepsin Z levels	344506	50	2666	6	2.536224065473854e-06	0.0042329579652758	27	0.056
level2	Lysosomal protective protein levels	344506	8	2666	3	2.5181239874118397e-05	0.0420274893499036	22	0.046
level2	Galectin-2 levels	344506	5	2666	4	1.7781162575479062e-08	2.967676033847455e-05	55	0.112
level2	Luteinizing hormone levels	344506	3	2666	3	4.629189831887452e-07	0.000772611782942	69	0.14
level2	Alpha-L-iduronidase levels	344506	60	2666	6	7.480448482534369e-06	0.0124848685173498	20	0.042
level2	Signal-regulatory protein beta-1 levels (SIRPB1.6247.9.3)	344506	5	2666	3	4.575680443270919e-06	0.0076368106598191	30	0.062
level2	Killer cell immunoglobulin-like receptor 2DL5A levels (KIR2DL5A.8000.17.3)	344506	13	2666	4	2.419787541353806e-06	0.0040386254065195	41	0.084
level2	Killer cell immunoglobulin-like receptor 2DS2 levels (KIR2DS2.10428.1.3)	344506	6	2666	6	2.1357668426827642e-13	3.5645948604375326e-10	139	0.279
level2	Human Chorionic Gonadotropin levels (CGA.CGB.4914.10.1)	344506	3	2666	3	4.629189831887452e-07	0.000772611782942	69	0.14
level2	Ulcerative colitis x sex interaction (2df)	344506	14	2666	4	3.3668095311388177e-06	0.0056192051074706	23	0.048
level2	Hypothyroidism or rheumatoid arthritis (pleiotropy)	344506	1035	2666	326	0.0	0.0	216	0.433
level2	Seropositivity for streptococcus agalactiae peptide (agilent_234887)	344506	20	2666	7	1.1706447191208743e-10	1.9538060362127398e-07	99	0.2
level2	Seropositivity for streptococcus agalactiae peptide (agilent_241118)	344506	49	2666	7	1.0663694429588953e-07	0.0001779770600298	54	0.11
level2	Seropositivity for streptococcus pyogenes peptide (agilent_220658)	344506	50	2666	7	1.231628172115434e-07	0.000205558741926	68	0.138
level2	Seropositivity for streptococcus pneumoniae peptide (agilent_229757)	344506	18	2666	4	1.004074713124838e-05	0.0167580069620535	71	0.144
level2	Seropositivity for streptococcus pyogenes peptide (agilent_241884)	344506	49	2666	6	2.2466567134989787e-06	0.0037496700548297	54	0.11
level2	Seropositivity for staphylococcus aureus peptide (agilent_222381)	344506	47	2666	6	1.7480395214002465e-06	0.002917477961217	61	0.124
level3	Blood protein levels	344506	1150	4430	36	1.7130028899527784e-06	0.0049437263404037	115	0.232
level3	Mean corpuscular hemoglobin	344506	2366	4430	67	4.610313958273849e-09	1.3305366083578328e-05	219	0.439
level3	Crohn's disease	344506	477	4430	38	1.2858725978573344e-18	3.711028317416267e-15	230	0.461
level3	Mean corpuscular volume	344506	2227	4430	65	2.480668104474261e-09	7.159208149512717e-06	201	0.403
level3	Creatine kinase levels in statin users	344506	4	4430	3	8.417526243175588e-06	0.0242929807378047	2	0.006
level3	Hypertriglyceridemia	344506	43	4430	13	6.598213615981914e-15	1.9042444495723805e-11	65	0.132
level3	Inflammatory bowel disease	344506	665	4430	32	4.1156243332718635e-10	1.18776918258226e-06	247	0.495
level3	Ulcerative colitis	344506	307	4430	19	2.8718701430953196e-08	8.288217232973091e-05	220	0.441
level3	Triglycerides	344506	869	4430	31	6.213480788036689e-07	0.0017932105554273	75	0.152
level3	HDL cholesterol	344506	712	4430	34	1.4573833500750783e-10	4.206008348316676e-07	41	0.084
level3	Takayasu arteritis	344506	144	4430	20	4.858745677372947e-15	1.4022340024898324e-11	212	0.425
level3	Neutrophil count	344506	1560	4430	42	1.03057464140602e-05	0.0297423841509777	388	0.776
level3	Idiopathic membranous nephropathy	344506	21	4430	5	6.01180938244264e-06	0.0173500818777294	199	0.399
level3	HIV-1 control	344506	46	4430	8	1.2548805376708733e-07	0.0003621585231718	62	0.126
level3	Metabolic syndrome	344506	182	4430	19	4.243527026093649e-12	1.2246818997306272e-08	66	0.134
level3	Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	344506	10	4430	4	5.389825623636041e-06	0.0155550367498136	49	0.1
level3	Low HDL-cholesterol levels	344506	24	4430	8	4.548375531858968e-10	1.3126611784944982e-06	65	0.132
level3	Triglyceride levels	344506	2758	4430	71	6.750704899996903e-08	0.0001948253434139	65	0.132
level3	High density lipoprotein cholesterol levels	344506	2142	4430	89	3.6683613495604326e-21	1.0586890854831408e-17	112	0.226
level3	Serum metabolite levels (CMS)	344506	132	4430	10	9.208597993629548e-06	0.0265760138096148	58	0.118
level3	MHC class I polypeptide-related sequence A levels	344506	79	4430	21	6.849974629533502e-22	1.9769026780833693e-18	196	0.393
level3	Hip circumference adjusted for BMI	344506	3359	4430	158	9.445653538091018e-43	2.7260156110930678e-39	334	0.669
level3	Psoriasis vulgaris	344506	51	4430	7	4.083170884142313e-06	0.0117840311716347	16	0.034
level3	Waist-to-hip ratio adjusted for BMI	344506	3741	4430	123	3.415131429540561e-20	9.856069305654057e-17	363	0.727
level3	Serum levels of protein LILRA5	344506	4	4430	3	8.417526243175588e-06	0.0242929807378047	19	0.04
level3	Serum levels of protein LILRB2	344506	4	4430	4	2.7305299478367404e-08	7.880309429456833e-05	19	0.04
level3	Alzheimer's disease or family history of Alzheimer's disease	344506	309	4430	17	7.804196019551319e-07	0.0022522909712425	79	0.16
level3	Non-melanoma skin cancer	344506	234	4430	20	4.6167303297983177e-11	1.3323883731797946e-07	166	0.333
level3	Waist-hip index	344506	2526	4430	99	1.3774668679203475e-21	3.975369380818122e-18	377	0.754
level3	Household income (MTAG)	344506	343	4430	18	7.410052519814989e-07	0.0021385411572186	72	0.146
level3	Worry	344506	147	4430	11	3.752081532251522e-06	0.0108285073020778	94	0.19
level3	Natural cytotoxicity triggering receptor 3 levels	344506	9	4430	4	3.267405272287199e-06	0.0094297316158208	8	0.018
level3	MHC class I polypeptide-related sequence B levels	344506	29	4430	10	1.9618480164549414e-12	5.6618933754889605e-09	102	0.206
level3	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels	344506	54	4430	9	3.0107752829955474e-08	8.689097466725148e-05	23	0.048
level3	Killer cell immunoglobulin-like receptor 2DL4 levels	344506	15	4430	7	3.4020167936277016e-10	9.818220466409547e-07	47	0.096
level3	A body shape index	344506	1514	4430	70	2.298844076319957e-19	6.634464004259395e-16	268	0.537
level3	Leukocyte immunoglobulin-like receptor subfamily B member 1 levels (LILRB1.5090.49.2)	344506	11	4430	10	1.3304810365648358e-18	3.839768271526116e-15	23	0.048
level3	Leukocyte immunoglobulin-like receptor subfamily B member 2 levels (LILRB2.5633.65.3)	344506	6	4430	4	4.012052159048253e-07	0.0011578782531013	21	0.044
level3	Diacylglycerol_36:2_[M+H-H2O]1+ levels	344506	43	4430	19	6.826235015142931e-25	1.9700514253702502e-21	93	0.188
level3	Diacylglycerol_36:3_[M+H-H2O]1+ levels	344506	42	4430	20	5.745633147603939e-27	1.658189726398497e-23	93	0.188
level3	Diacylglycerol(34:2)_[M+H-H2O]1+ levels	344506	66	4430	38	2.9029879629284815e-54	8.378023261011599e-51	65	0.132
level3	Diacylglycerol_34:1_[M+H-H2O]1+ levels	344506	22	4430	14	9.618514999754017e-22	2.7759034289290095e-18	65	0.132
level3	Diacylglycerol_34:2_[M+H-H2O]1+ levels	344506	33	4430	19	7.891187925414678e-28	2.277396835274676e-24	65	0.132
level3	Diacylglycerol(34:1)_[M+H-H2O]1+ levels	344506	60	4430	38	1.2974491620379426e-56	3.7444382816415023e-53	65	0.132
level3	Diacylglycerol_44:7_[M+H-H2O]1+ levels	344506	38	4430	13	1.0370041409005758e-15	2.9927939506390617e-12	94	0.19
level3	Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels	344506	18	4430	10	4.875506326961219e-15	1.4070711259610078e-11	65	0.132
level3	Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels	344506	17	4430	11	1.810149683094331e-17	5.224091985410238e-14	65	0.132
level3	Cholesteryl ester_18:0_[M+NH4]1+ levels	344506	10	4430	4	5.389825623636041e-06	0.0155550367498136	51	0.104
level3	Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levels	344506	53	4430	18	3.765230820411705e-21	1.086645614770818e-17	94	0.19
level3	Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levels	344506	36	4430	10	2.2937530521565988e-11	6.619771308523945e-08	66	0.134
level3	Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels	344506	25	4430	5	1.5038685065841946e-05	0.0434016451000198	26	0.054
level3	Cholesteryl ester(20:3)_[M+NH4]1+ levels	344506	64	4430	8	1.7338651165686006e-06	0.0050039347264169	70	0.142
level3	Sphingomyelin_38:1_[M+H]1+ levels	344506	64	4430	19	5.752195597048979e-21	1.6600836493083354e-17	65	0.132
level3	Sphingomyelin_36:2_[M+H]1+ levels	344506	37	4430	11	9.873898852401085e-13	2.849607208802952e-09	93	0.188
level3	Sphingomyelin_34:0_[M+H]1+ levels	344506	37	4430	13	6.904481174093367e-16	1.9926332668433453e-12	94	0.19
level3	Sphingomyelin_34:1_[M+H]1+ levels	344506	33	4430	11	2.3431374445986604e-13	6.762294665111733e-10	94	0.19
level3	Sphingomyelin_40:2_[M+H]1+ levels	344506	19	4430	8	4.9497246127783446e-11	1.4284905232478305e-07	65	0.132
level3	Sphingomyelin_36:0_[M+H]1+ levels	344506	29	4430	12	8.537890767843465e-16	2.464035275599624e-12	94	0.19
level3	Sphingomyelin_36:1_[M+H]1+ levels	344506	35	4430	12	1.2782903691162702e-14	3.689146005269556e-11	94	0.19
level3	Sphingomyelin_34:2_[M+H]1+ levels	344506	33	4430	14	2.1577000274182494e-18	6.227122279129068e-15	93	0.188
level3	Sphingomyelin(42:3)_[M+H]1+ levels	344506	71	4430	42	1.5165964071643178e-60	4.376897231076221e-57	65	0.132
level3	Sphingomyelin(42:4)_[M+H]1+ levels	344506	59	4430	31	8.547061546643103e-43	2.4666819623611995e-39	65	0.132
level3	Triacylglycerol(52:3)_[M+NH4]1+ levels	344506	44	4430	15	6.8762249164158636e-18	1.9844785108776182e-14	65	0.132
level3	Triacylglycerol_46:5_[M+NH4]1+ levels	344506	20	4430	9	1.4096680885877085e-12	4.068302103664126e-09	65	0.132
level3	Triacylglycerol_53:3_[M+NH4]1+ levels	344506	13	4430	6	7.156188513737098e-09	2.0652760050645262e-05	65	0.132
level3	Triacylglycerol_52:3_[M+NH4]1+ levels	344506	17	4430	10	2.192447061977824e-15	6.327402220868e-12	65	0.132
level3	Triacylglycerol(53:3)_[M+NH4]1+ levels	344506	48	4430	24	9.418006873448816e-33	2.7180367836773284e-29	65	0.132
level3	Triacylglycerol(53:2)_[M+NH4]1+ levels	344506	11	4430	4	8.38289993485133e-06	0.0241930492119809	43	0.088
level3	Killer cell immunoglobulin-like receptor 2DL5A levels (KIR2DL5A.8000.17.3)	344506	13	4430	8	9.028411405595965e-13	2.6055995316549952e-09	67	0.136
level3	Killer cell immunoglobulin-like receptor 2DS2 levels (KIR2DS2.10428.1.3)	344506	6	4430	4	4.012052159048253e-07	0.0011578782531013	163	0.327
level3	Rheumatoid arthritis or multiple sclerosis	344506	53	4430	9	2.538139909819433e-08	7.325071779738885e-05	247	0.495
level3	Verbal learning	344506	131	4430	87	1.1922919818349421e-130	3.4409546595756426e-127	103	0.208
level3	Rheumatoid arthritis or type 1 diabetes	344506	107	4430	17	5.420163380176949e-14	1.5642591515190675e-10	132	0.265
level3	Rheumatoid arthritis or irritable bowel disease	344506	86	4430	19	2.753177334039342e-18	7.945669786037541e-15	234	0.469
level3	5,6-dihydrothymine levels	344506	3	4430	3	2.124860534320361e-06	0.0061323475020485	114	0.23
level3	Multi-trait sex score	344506	2285	4430	62	7.512926241971014e-08	0.0002168230513432	81	0.164
level3	Allergen component sensitization (Hevea brasiliensis 8)	344506	77	4430	22	1.2406144424959314e-23	3.580413281043258e-20	143	0.287
level3	Hypothyroidism or rheumatoid arthritis (pleiotropy)	344506	1035	4430	63	1.5770760911766632e-23	4.55144159913585e-20	371	0.743
level3	Seropositivity for staphylococcus aureus subsp. aureus MRSA252 peptide (agilent_84757)	344506	21	4430	5	6.01180938244264e-06	0.0173500818777294	132	0.265
level3	Seropositivity for clostridiales peptide (agilent_68956)	344506	17	4430	5	1.9082195331250333e-06	0.0055071215725988	128	0.257
level3	Seropositivity for lactobacillus phage LFEINF peptide (twist_88894)	344506	18	4430	6	7.325746501643266e-08	0.0002114210440374	117	0.236
level3	Seropositivity for lactobacillus phage LFEINF peptide (twist_64023)	344506	18	4430	6	7.325746501643266e-08	0.0002114210440374	108	0.218
level4	Eosinophil counts	344506	2100	6724	97	2.7592693026540673e-14	9.712627945342316e-11	474	0.948
level4	Eosinophil percentage of white cells	344506	749	6724	36	1.2096877732897925e-06	0.00425810096198	105	0.212
level4	Monocyte count	344506	1767	6724	73	4.514300620370093e-09	1.5890338183702727e-05	453	0.906
level4	Lymphocyte count	344506	1651	6724	61	2.9573500142424e-06	0.0104098720501332	332	0.665
level4	Asthma	344506	997	6724	48	2.201116488979175e-08	7.747930041206695e-05	180	0.361
level4	Parkinson's disease	344506	374	6724	30	1.2662127897480087e-10	4.457069019912991e-07	195	0.391
level4	Crohn's disease	344506	477	6724	26	3.872203387221488e-06	0.0136301559230196	365	0.731
level4	Cutaneous lupus erythematosus	344506	7	6724	6	3.796756960461227e-10	1.3364584500823518e-06	85	0.172
level4	White blood cell count	344506	2803	6724	98	5.329711631285549e-08	0.0001876058494212	447	0.894
level4	Inflammatory bowel disease	344506	665	6724	44	5.2211093921821995e-12	1.8378305060481344e-08	395	0.79
level4	Ulcerative colitis	344506	307	6724	38	3.308429299960702e-19	1.1645671135861672e-15	376	0.752
level4	IgA nephropathy	344506	159	6724	18	2.932352287980316e-09	1.0321880053690712e-05	189	0.379
level4	Systemic lupus erythematosus	344506	863	6724	60	8.929207425671742e-17	3.1430810138364543e-13	270	0.541
level4	Type 1 diabetes and autoimmune thyroid diseases	344506	11	6724	5	1.1844438394604451e-06	0.0041692423149007	27	0.056
level4	Takayasu arteritis	344506	144	6724	14	1.0557820838962617e-06	0.0037163529353148	295	0.591
level4	Hip circumference adjusted for BMI	344506	3359	6724	102	1.3677757097943936e-05	0.0481457049847626	393	0.786
level4	L-selectin levels	344506	53	6724	9	8.342778937466466e-07	0.0029366581859881	75	0.152
level4	Neutrophil count	344506	1560	6724	73	2.170724805498949e-11	7.640951315356301e-08	463	0.926
level4	Idiopathic membranous nephropathy	344506	21	6724	12	7.556607785117852e-16	2.659925940361484e-12	266	0.533
level4	Nodular sclerosis Hodgkin lymphoma	344506	14	6724	5	4.88718001055738e-06	0.0172028736371619	165	0.331
level4	Disc degeneration (lumbar)	344506	36	6724	12	2.452193435799437e-12	8.631720894014018e-09	197	0.395
level4	Multiple sclerosis (OCB status)	344506	10	6724	6	1.0828991798743568e-08	3.811805113157736e-05	192	0.385
level4	Economic and political preferences (environmentalism)	344506	17	6724	7	1.7616579431069946e-08	6.20103595973662e-05	27	0.056
level4	Graves' disease	344506	76	6724	10	2.3521718961067124e-06	0.0082796450742956	6	0.014
level4	ACPA-positive rheumatoid arthritis (smoking interaction)	344506	15	6724	10	2.1888035972861433e-14	7.704588662447222e-11	192	0.385
level4	Waist-to-hip ratio adjusted for BMI	344506	3741	6724	167	5.3566998953021195e-22	1.8855583631463456e-18	408	0.816
level4	Epstein Barr virus nuclear antigen 1 IgG levels	344506	6	6724	4	2.107550998943581e-06	0.0074185795162814	192	0.385
level4	Shingles	344506	86	6724	10	7.312243862801697e-06	0.0257390983970619	33	0.068
level4	Meningococcal C functional antibody titers post childhood immunization	344506	6	6724	5	1.6693823989589072e-08	5.876226044335352e-05	280	0.561
level4	Immunoglobulin A vasculitis	344506	60	6724	44	5.765785205015449e-62	2.029556392165438e-58	192	0.385
level4	Chitinase-3-like protein 1 levels	344506	41	6724	7	1.3508916581728016e-05	0.0475513863676826	9	0.02
level4	CD62L on monocyte	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	45	0.092
level4	Type 1 diabetes (age at diagnosis)	344506	40	6724	7	1.139508567390184e-05	0.0401107015721344	156	0.313
level4	CD22/FCER2 protein level ratio	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	0	0.002
level4	Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)	344506	25	6724	10	1.993009663264224e-11	7.015394014690067e-08	137	0.275
level4	Response to hepatitis B vaccine	344506	21	6724	7	9.834555134167537e-08	0.0003461763407226	186	0.373
level4	Childhood steroid-sensitive nephrotic syndrome	344506	29	6724	7	1.1510669781316318e-06	0.0040517557630233	188	0.377
level4	A body shape index	344506	1514	6724	84	6.678046553363937e-17	2.3506723867841057e-13	345	0.691
level4	Waist-hip index	344506	2526	6724	134	2.874085721206857e-24	1.0116781738648136e-20	415	0.83
level4	Inguinal hernia	344506	2192	6724	138	4.265285819918304e-32	1.501380608611243e-28	132	0.265
level4	General factor of neuroticism	344506	308	6724	25	3.311052062187201e-09	1.1654903258898946e-05	196	0.393
level4	Anti-anoctamin 2 antibody levels	344506	10	6724	8	9.113894395952042e-13	3.208090827375118e-09	170	0.341
level4	Cathepsin S levels	344506	32	6724	7	2.358203954620273e-06	0.0083008779202633	2	0.006
level4	Low affinity immunoglobulin epsilon Fc receptor levels	344506	52	6724	8	7.341836206579816e-06	0.0258432634471609	6	0.014
level4	Tartrate-resistant acid phosphatase type 5 levels	344506	39	6724	9	5.10247978150804e-08	0.000179607288309	40	0.082
level4	Ubiquitin carboxyl-terminal hydrolase 25 levels (USP25.9215.117.3)	344506	15	6724	6	2.372731636032642e-07	0.0008352015358834	110	0.222
level4	CD177 antigen levels (CD177.13116.25.3)	344506	8	6724	5	1.5078897472569476e-07	0.0005307771910344	58	0.118
level4	Rheumatoid arthritis or multiple sclerosis	344506	53	6724	15	6.950620244741849e-14	2.4466183261491307e-10	314	0.629
level4	Vaginal microbiome presence (c_Actinobacteria)	344506	13	6724	5	3.1934646325400907e-06	0.0112409955065411	89	0.18
level4	Rheumatoid arthritis or type 1 diabetes	344506	107	6724	12	1.3505688021804453e-06	0.0047540021836751	231	0.463
level4	Rheumatoid arthritis or irritable bowel disease	344506	86	6724	16	1.1575015487392516e-11	4.0744054515621666e-08	328	0.657
level4	5,6-dihydrothymine levels	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	100	0.202
level4	Pediatric steroid sensitive nephrotic syndrome	344506	41	6724	9	8.14381893875579e-08	0.0002866624266442	162	0.325
level4	Allergen component sensitization (Hevea brasiliensis 8)	344506	77	6724	26	3.0050974726941928e-25	1.057794310388356e-21	283	0.567
level4	Hypothyroidism or rheumatoid arthritis (pleiotropy)	344506	1035	6724	450	0.0	0.0	432	0.864
level4	Seropositivity for aix galericulata (mandarin duck) peptide (twist_23200)	344506	11	6724	5	1.1844438394604451e-06	0.0041692423149007	150	0.301
level4	Seropositivity for blautia producta peptide (agilent_74695)	344506	11	6724	5	1.1844438394604451e-06	0.0041692423149007	109	0.22
level4	Seropositivity for streptococcus agalactiae peptide (agilent_234887)	344506	20	6724	17	9.150225673001735e-27	3.220879436896612e-23	268	0.537
level4	Seropositivity for streptococcus agalactiae peptide (agilent_241118)	344506	49	6724	16	7.929912745734789e-16	2.7913292864986457e-12	163	0.327
level4	Seropositivity for streptococcus pneumoniae peptide (agilent_224401)	344506	14	6724	10	7.427531884636546e-15	2.6144912233920643e-11	176	0.353
level4	Seropositivity for gallus gallus ovomucoid precursor gallus peptide (twist_1603)	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	8	0.018
level4	Seropositivity for staphylococcus aureus subsp. aureus MRSA252 peptide (agilent_84757)	344506	21	6724	10	2.309656274001004e-12	8.129990084483533e-09	214	0.429
level4	Seropositivity for staphylococcus aureus subsp. aureus MW2 peptide (agilent_235512)	344506	14	6724	10	7.427531884636546e-15	2.6144912233920643e-11	166	0.333
level4	Seropositivity for streptococcus pneumoniae peptide (twist_54623)	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	47	0.096
level4	Seropositivity for streptococcus phage peptide (twist_76831)	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	41	0.084
level4	Seropositivity for clostridiales peptide (agilent_68956)	344506	17	6724	7	1.7616579431069946e-08	6.20103595973662e-05	215	0.431
level4	Seropositivity for streptococcus pneumoniae peptide (agilent_223208)	344506	26	6724	15	1.4118090432453557e-19	4.969567832223651e-16	184	0.369
level4	Seropositivity for streptococcus pneumoniae peptide (agilent_227833)	344506	13	6724	6	8.413245674813346e-08	0.0002961462477534	98	0.198
level4	Seropositivity for streptococcus pneumoniae peptide (agilent_241214)	344506	14	6724	7	3.2731344394886363e-09	1.1521433227000002e-05	99	0.2
level4	Seropositivity for streptococcus pneumoniae peptide (agilent_236127)	344506	13	6724	7	1.6649250482457642e-09	5.860536169825091e-06	113	0.228
level4	Seropositivity for streptococcus pneumoniae peptide (agilent_220184)	344506	14	6724	8	5.671565643481112e-11	1.9963911065053518e-07	119	0.24
level4	Seropositivity for streptococcus pneumoniae peptide (agilent_223641)	344506	11	6724	5	1.1844438394604451e-06	0.0041692423149007	55	0.112
level4	Seropositivity for streptococcus pneumoniae peptide (twist_48171)	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	47	0.096
level4	Seropositivity for streptococcus pyogenes peptide (agilent_220658)	344506	50	6724	17	4.53196857926481e-17	1.595252939901213e-13	178	0.357
level4	Seropositivity for streptococcus pneumoniae peptide (agilent_229757)	344506	18	6724	12	5.039438542810873e-17	1.7738823670694274e-13	174	0.349
level4	Seropositivity for streptococcus pneumoniae peptide (agilent_223825)	344506	11	6724	7	3.3137464870803254e-10	1.1664387634522748e-06	188	0.377
level4	Seropositivity for escherichia virus p1 peptide (twist_92719)	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	50	0.102
level4	Seropositivity for gallus peptide (twist_24274)	344506	7	6724	5	5.7479194753501263e-08	0.0002023267655323	147	0.295
level4	Seropositivity for oryza sativa (rice) peptide (twist_19685)	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	47	0.096
level4	Seropositivity for human gammaherpesvirus 4 (Epstein-Barr virus) peptide (twist_46937)	344506	4	6724	4	1.449918606329284e-07	0.0005103713494279	165	0.331
level4	Seropositivity for staphylococcaceae peptide (agilent_4825)	344506	15	6724	8	1.1943027667167487e-10	4.2039457388429566e-07	138	0.277
level4	Seropositivity for staphylococcus aureus peptide (twist_35030)	344506	11	6724	8	3.283877430602272e-12	1.1559248555719995e-08	170	0.341
level4	Seropositivity for human gammaherpesvirus 4 (Epstein-Barr virus) peptide (twist_32108)	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	41	0.084
level4	Seropositivity for lactobacillus phage LFEINF peptide (twist_88894)	344506	18	6724	6	8.368227226374787e-07	0.0029456159836839	185	0.371
level4	Seropositivity for triticum urartu (wild einkorn wheat) peptide (twist_11627)	344506	10	6724	5	6.567085183312674e-07	0.002311613984526	68	0.138
level4	Seropositivity for streptococcus pyogenes peptide (agilent_241884)	344506	49	6724	13	8.035527777541273e-12	2.8285057776945282e-08	139	0.279
level4	Seropositivity for staphylococcus aureus peptide (twist_46764)	344506	9	6724	7	3.741485634878648e-11	1.3170029434772841e-07	172	0.345
level4	Seropositivity for staphylococcus aureus peptide (twist_39975)	344506	9	6724	5	3.337687551969375e-07	0.0011748660182932	124	0.25
level4	Seropositivity for staphylococcus aureus peptide (agilent_236148)	344506	3	6724	3	7.431949258048143e-06	0.0261604613883294	43	0.088
level4	Seropositivity for staphylococcus aureus peptide (agilent_226247)	344506	15	6724	10	2.1888035972861433e-14	7.704588662447222e-11	203	0.407
level4	Seropositivity for staphylococcus aureus peptide (agilent_222381)	344506	47	6724	16	3.6942688676720796e-16	1.300382641420572e-12	166	0.333
level4	Seropositivity for staphylococcus aureus subsp. aureus MRSA252 peptide (agilent_188119)	344506	5	6724	5	2.8282718351721927e-09	9.955516859806118e-06	140	0.281
level4	Seropositivity for staphylococcus aureus peptide (agilent_236333)	344506	12	6724	6	4.607051901096687e-08	0.0001621682269186	100	0.202
level4	Seropositivity for staphylococcus aureus peptide (agilent_222322)	344506	7	6724	4	4.840980072902667e-06	0.0170402498566173	97	0.196
